A detailed history of Arizona State Retirement System transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 16,000 shares of SWTX stock, worth $569,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 15,491 3.29%
Holding current value
$569,440
Previous $583,000 12.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$32.04 - $42.76 $16,308 - $21,764
509 Added 3.29%
16,000 $512,000
Q2 2024

Aug 05, 2024

BUY
$36.06 - $47.62 $94,405 - $124,669
2,618 Added 20.34%
15,491 $583,000
Q1 2024

May 07, 2024

SELL
$36.5 - $52.5 $7,847 - $11,287
-215 Reduced 1.64%
12,873 $633,000
Q4 2023

Jan 24, 2024

BUY
$18.94 - $37.24 $62,445 - $122,780
3,297 Added 33.67%
13,088 $477,000
Q3 2023

Nov 06, 2023

BUY
$23.12 - $31.38 $3,051 - $4,142
132 Added 1.37%
9,791 $226,000
Q2 2023

Aug 01, 2023

SELL
$23.15 - $32.71 $6,528 - $9,224
-282 Reduced 2.84%
9,659 $253,000
Q1 2023

Apr 27, 2023

BUY
$24.97 - $34.05 $248,226 - $338,491
9,941 New
9,941 $255,000
Q3 2022

Nov 07, 2022

BUY
$24.1 - $39.66 $177,978 - $292,889
7,385 New
7,385 $211,000
Q2 2022

Jul 28, 2022

SELL
$18.36 - $60.07 $97,767 - $319,872
-5,325 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$48.97 - $65.46 $1,762 - $2,356
36 Added 0.68%
5,325 $301,000
Q4 2021

Feb 04, 2022

SELL
$53.3 - $75.84 $3,038 - $4,322
-57 Reduced 1.07%
5,289 $328,000
Q3 2021

Nov 12, 2021

BUY
$62.66 - $88.26 $1,315 - $1,853
21 Added 0.39%
5,346 $339,000
Q2 2021

Aug 02, 2021

SELL
$67.45 - $85.63 $23,809 - $30,227
-353 Reduced 6.22%
5,325 $439,000
Q1 2021

May 06, 2021

BUY
$65.1 - $93.59 $7,811 - $11,230
120 Added 2.16%
5,678 $418,000
Q4 2020

Jan 28, 2021

BUY
$48.36 - $77.92 $268,784 - $433,079
5,558 New
5,558 $403,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.22B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.